Drug eluting stent and coronary chronic total occlusions

Minerva Cardioangiologica

Volumn 59, Issue 3, 2011, Pages 271-284

  Niccoli, G ^a   Leo, A ^a   Giubilato, S ^a   Cosentino, N ^a   Minelli, S ^a   Galiffa, V A ^a   Crea, F ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Coronary angiography; Coronary occlusion; Drug eluting stents

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ANEURYSM; ANGIOCARDIOGRAPHY; BARE METAL STENT; CHRONIC TOTAL OCCLUSION; CORONARY ARTERY RECANALIZATION; DEVICE SAFETY; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; FOLLOW UP; HEART INFARCTION; HUMAN; REVIEW; THROMBOSIS;

ANGIOPLASTY, BALLOON, CORONARY; CHRONIC DISEASE; CORONARY ANGIOGRAPHY; CORONARY OCCLUSION; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; HUMANS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STENTS; TREATMENT OUTCOME;

EID: 79960646020     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (60)

1. Cohen HA, Williams DO, Holmes DR Jr, Selzer F, Kip KE, Johnston JM, Holubkov R et al. NHLBI Dynamic Registry. Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry. Am Heart J 2003;146:513-9.
2. Anderson HV, Shaw RE, Brindis RG, Hewitt K, Krone RJ, Block PC et al. A contemporary overview of percutaneous coronary interventions: The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). J Am Coll Cardiol 2002;39:1096-103. (Pubitemid 34267410)
3. Grantham A, Marso SP, Spertus J. Chronic total occlusion angioplasty in the United States. J Am Coll Cardiol Intv 2009;2:479-86.
4. Di Mario C, Werner GS, Sianos G, Galassi AR, Büttner J, Dudek D et al. European perspective in the recanalisation of Chronic Total Occlusions (CTO):consensus document from the EuroCTO Club. EuroIntervention 2007;3:30-43.
5. Hoye A. The how and why of...chronic total occlusions. Part Two: Why we treat CTOs the way we do. EuroIntervention 2006;2:382-8.
6. Rubartelli P, Niccoli L, Verna E, Giachero C, Zimarino M, Fontanelli A et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions:results from the GISSOC trial. Gruppo Italiano di Studio sullo Stent nelle Occlusioni Coronariche. J Am Coll Cardiol 1998;32:90-6. (Pubitemid 28351047)
7. Sirnes PA, Golf S, Myreng Y, Mølstad P, Emanuelsson H, Albertsson P cet al. Stenting in chronic coronary occlusion (SICCO):a randomised, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996;28:1444-51. (Pubitemid 26391848)
8. Buller CE, Dzavik V, Carere RG, Mancini GB, Barbeau G, Lazzam C et al. Primary stenting versus balloon angioplasty in occluded coronary arteries:the total occlusion study of Canada (TOSCA). Circulation 1999;100:236-42. (Pubitemid 29340128)
9. Höher M, Wöhrle J, Grebe OC, Kochs M, Osterhues HH, Hombach V et al. A randomised trial of elective stenting after balloon recanalization of chronic total occlusions. J Am Coll Cardiol 1999;34:722-9. (Pubitemid 29436177)
10. Mori M, Kurogane H, Hayashi T, Yasaka Y, Ohta S, Kajiya T et al. Comparison of results of intracoronary implantation of the Palmaz-Schatz stent with conventional balloon angioplasty in chronic total coronary arterial occlusion. Am J Cardiol 1996;78:985-9. (Pubitemid 126658673)
11. Lotan C, Rozenman Y, Hendler A, Turgeman Y, Ayzenberg O, Beyar R et al. Stents in total occlusion for restenosis prevention. The multicentre randomised STOP study. The Israeli working group for interventional cardiology. Eur Heart J 2002;21:1960-6.
12. Carlsson J, James SK, Lindback J, Lindbäck J, Scherstén F, Nilsson T, Stenestrand U et al. Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria. J Am Coll Cardiol 2009;53:1389-98.
13. Suero JA, Marso SP, Jones PG, Laster SB, Huber KC, Giorgi LV et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries:a 20-year experience. J Am Coll Cardiol 2001;38:409-14. (Pubitemid 32721768)
14. Hoye A, van Domburg RT, Sonnenschein K, Serruys PW. Percutaneous coronary intervention for chronic total occlusions:the Thoraxcenter experience 1992-2002. Eur Heart J 2005;26:2630-6.
15. Valenti R, Migliorini A, Signorini U, Vergara R, Parodi G, Carrabba N et al. Impact of complete revascularization with percutaneous coronary intervention on survival in patients with at least one chronic total occlusion. Eur Heart J 2008;29:2336-42.
16. Olivari Z, Rubartelli P, Piscione F, Ettori F, Fontanelli A, Salemme et al. Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions:data from a multicenter, prospective, observational study (TOAST-GISE). J Am Coll Cardiol 2003;41:1672-8. (Pubitemid 36584233)
17. Kirschbaum SW, Baks T, van den Ent M, Sianos G, Krestin GP, Serruys PW et al. Evaluation of left ventricular function three years after percutaneous recanalization of chronic total coronary occlusions. Am J Cardiol 2008;101:179-85.
18. Suero JA, Marso SP, Jones PG, Laster SB, Huber KC, Giorgi LV et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries:a 20-year experience. J Am Coll Cardiol 2001;38:409-14. (Pubitemid 32721768)
19. Hoye A, van Domburg RT, Sonnenschein K, Serruys PW. Percutaneous coronary intervention for chronic total occlusions:the Thoraxcenter experience 1992-2002. Eur Heart J 2005;26:2630-6.
20. Zimarino M, Ausiello A, Contegiacomo G, Riccardi I, Renda G, Di Iorio C et al. Rapid decline of collateral circulation increases susceptibility to myocardial ischemia:the trade-off of successful percutaneous recanalization of chronic total occlusions. J Am Coll Cardiol 2006;48:59-65. (Pubitemid 43929224)
21. Werner GS, Bahrmann P, Mutschke O, Emig U, Betge S, Ferrari M et al. Determinants of target vessel failure in chronic total coronary occlusions after stent implantation. The influence of collateral function and coronary hemodynamics. J Am Coll Cardiol 2003;42:219-25. (Pubitemid 36851409)
22. Werner GS, Emig U, Mutschke O, Schwarz G, Bahrmann P, Figulla HR. Regression of Collateral Function After Recanalization of Chronic Total Coronary Occlusions:A Serial Assessment by Intracoronary Pressure and Doppler Recordings. Circulation 2003;108:2877-82. (Pubitemid 37517815)
23. Stone GW, Rutherford BD, McConahay DR, Johnson WL Jr, Giorgi LV, Ligon RW et al. Procedural outcome of angioplasty for total coronary artery occlusion:an analysis of 971 lesions in 905 patients. J Am Coll Cardiol 1990;15:849-56. (Pubitemid 20101578)
24. Ivanhoe RJ, Weintraub WS, Douglas Jr JS, Lembo NJ, Furman M, Gershony G et al. Percutaneous transluminal coronary angioplasty of chronic total occlusions.primary success, restenosis, and long-term clinical follow-up. Circulation 1992;85:106-15. 6-501.
25. Agostoni P, Valgimigli M, Biondi-Zoccai GG, Abbate A, Garcia Garcia HM, Anselmi M et al. Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions:insights from a systematic overview of randomized trials in light of the drug-eluting stent era. Am Heart J 2006;151:682-9.
26. Elezi S, Kastrati A, Wehinger A, Walter H, Schühlen H, Hadamitzky M et al. Clinical and angiographic outcome after stent placement for chronic coronary occlusion. Am J Cardiol 1998;82:803-6, A9.
27. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M et al. RAVEL Study Group. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80. (Pubitemid 34586912)
28. Caixeta A, Leon MB, Lansky AJ, Nikolsky E, Aoki J, Moses JW et al. 5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents. J Am Coll Cardiol 2009;54:894-902.
29. Hoye A, Tanabe K, Lemos PA, Aoki J, Saia F, Arampatzis C et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. J Am Coll Cardiol 2004;43:1954-8. (Pubitemid 38686787)
30. Ge L, Iakovou I, Cosgrave J, Chieffo A, Montorfano M, Michev I et al. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions. Eur Heart J 2005;26:1056-62. (Pubitemid 40839905)
31. Nakamura S, Muthusamy TS, Bae JH, Cahyadi YH, Udayachalerm W, Tresukosol D. Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusions. Am J Cardiol 2005;95:161-.
32. Suttorp MJ, Laarman GJ, Rahel BM, Kelder JC, Bosschaert MA, Kiemeneij F et al. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II):a randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation 2006;114:921-8.
33. Rubartelli P, Petronio AS, Guiducci V, Sganzerla P, Bolognese L, Galli M et al. Comparison of sirolimus-eluting and bare metal stent for treatment of patients with total coronary occlusions: results of the GISSOC II-GISE multicentre randomized trial. Eur Heart J 2010 June 20 [E-pub ahead of print].
34. Werner GS, Krack A, Schwarz G, Prochnau D, Betge S, Figulla HR. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. J Am Coll Cardiol 2004;44:2301-6. (Pubitemid 39647602)
35. Werner GS, Schwarz G, Prochnau D, Fritzenwanger M, Krack A, Betge S et al. Paclitaxel-eluting stents for the treatment of chronic total coronary occlusions:A strategy of extensive lesion coverage with drug-eluting stents. Catheter Cardiovasc Interv 2006;67:1-9. (Pubitemid 43062598)
36. Hoye A, Ong ATL, Aoki J, van Mieghem CA, Rodriguez Granillo GA, Valgimigli M et al. Drug-eluting stent implantation for chronic total occlusions:comparison between the sirolimus- and paclitaxel-eluting stent. EuroIntervention 2005;1:193-7.
37. Migliorini A, Moschi G, Vergara R, Parodi G, Carrabba N, Antoniucci D. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion. Catheter Cardiovasc Interv 2006;67:344-8.
38. Rahel BM, Laarman GJ, Kelder JC, Ten Berg JM, Suttorp MJ. Three-year clinical outcome after primary stenting of totally occluded native coronary arteries:a randomized comparison of bare-metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (Primary Stenting of Totally Occluded Native Coronary Arteries [PRISON] II study). Am Heart J 2009;157:149-55.
39. De Felice F, Fiorilli R, Parma A, Nazzaro M, Musto C, Sbraga F et al. Clinical outcome of patients with chronic total occlusion treated with drug-eluting stents. Int J Cardiol 2009;132:337-41.
40. García-García HM, Daemen J, Kukreja N, Tanimoto S, van Mieghem CA, van der Ent M et al. Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital-(RESEARCH) registry. Catheter Cardiovasc Interv 2007;70:635-9. (Pubitemid 350144438)
41. Shen ZJ, García-García HM, Garg S, Onuma Y, Onuma Y, Schenkeveld L, van Domburg RT et al. Interventional Cardiologists at Thoraxcentre in 2000-2003. Five-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam Cardiology Hospital-(Research) Registry. Catheter Cardiovasc Interv 2009;74:979-86.
42. Han YL, Zhang J, Li Y, Wang SL, Jing QM, Yi XH et al. Long-term outcomes of drug-eluting versus baremetal stent implantation in patients with chronic total coronary artery occlusions. Chin Med J (Engl) 2009;122:643-7.
43. Colmenarez HJ, Escaned J, Fernández C, Lobo L, Cano S, del Angel JG et al. Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization:a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1854-66.
44. Jang JS, Hong MK, Lee CW, Park DW, Lee BK, Kim YH et al. Comparison between sirolimus- and Paclitaxel-eluting stents for the treatment of chronic total occlusions. J Invasive Cardiol 2006;18:205-8. (Pubitemid 44576070)
45. Lee SP, Kim SY, Park KW, Shin DH, Kang HJ, Koo BK et al. Long-term clinical outcome of chronic total occlusive lesions treated with drug-eluting stents:comparison of sirolimus-eluting and paclitaxel-eluting stents. Circ J 2010;74:693-70
46. Nakamura S, Bae J, Cahyadi YH, Udayachalerm W, Tresukosol D, Tansuphaswadikul S. Drug-eluting stents for the treatment of chronic total occlusion: a comparison of serial angiographic follow-up with sirolimus, paclitaxel, zotarolimus and tacrolimus-eluting stent: multicenter registry in Asia. Circulation 2006;114:II 687 (Abstract 3241).
47. Nakamura S. Drug-eluting stents for the treatment of chronic total occlusion: a comparison with sirolimus, paclitaxel, zotarolimus, biolimus A9, EPC capture and everolimus-eluting stent: multicenter registry in Asia. Abstract TCT-234.
48. Carter AJ. Drug-eluting stent fracture promise and performance. J Am Coll Cardiol 2009;54:1932-4.
49. Nakazawa G, Finn AV, Vorpahl M, Ladich E, Kutys R, Balazs I et al. Incidence and predictors of drug-eluting stent fracture in human coronary artery:a pathologic analysis. J Am Coll Cardiol 2009;54:1924-31.
50. Popma JJ, Tiroch K, Almonacid A, Cohen S, Kandzari DE, Leon MB. A qualitative and quantitative angiographic analysis of stent fracture late following sirolimus-eluting stent implantation. Am J Cardiol 2009;103.923-9.
51. Kandzari DE, Rao SV, Moses JW, Dzavik V, Strauss BH, Kutryk MJ et al. ACROSS/TOSCA-4 Investigators. Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions:the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial. JACC Cardiovasc Interv 2009;2:97-106.
52. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after baremetal stent implantation. Circulation 2004;109:881-6.
53. Nakamura M, Kataoka T, Honda Y, Bonneau HN, Hibi K, Kitamura K et al. Late incomplete stent apposition and focal vessel expansion after bare metal stenting. AmJ Cardiol 2003,92:1217-9. (Pubitemid 37377839)
54. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK et al. Late stent malapposition after drug-eluting stent implantation:an intravascular ultrasound analysis with long-term follow-up. Circulation 2006;113:414-9. (Pubitemid 43803203)
55. Hassan AK, Bergheanu SC, Stijnen T, van der Hoeven BL, Snoep JD, Plevier JW et al. Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis. Eur Heart J 2010;31:1172-80.
56. Tsuchikane E, Suzuki T, Asakura Y, Oda H, Ueda K, Tanaka T et al. DOCTORS Investigators. Debulking of chronic coronary total occlusions with rotational or directional atherectomy before stenting.Final results of DOCTORS study. Int J Cardiol 2008;125:397-403. (Pubitemid 351418052)
57. Aoki J, Kirtane A, Leon MB, Dangas G. Coronary artery aneurysms after drug-eluting stent implantation. JACC Cardiovasc Interv 2008;1:14-21. (Pubitemid 351445418)
58. Alfonso F, Pérez-Vizcayno MJ, Ruiz M, Suárez A, Cazares M, Hernández R et al. Coronary aneurysms after drug-eluting stent implantation:clinical, angiographic, and intravascular ultrasound findings. J Am Coll Cardiol 2009;53:2053-60.
59. Silber S, Albertsson P, Avilés FF, Camici PG, Colombo A, Hamm C et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005;26.804-47.
60. Park SJ, Park DW, Kim YH, Kang SJ, Lee SW, Lee CW et al. Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med 2010;362:1374-82.